Rapid Novor Inc is developing a sensitive and non-invasive blood based liquid biopsy to monitor the minimal residue disease and detect early relapse for Multiple Myeloma.
Contact this Exhibitor
International callers dial 001 703-449-6418
Monday - Friday 9 a.m. - 5 p.m. Eastern Time